David Collister
MD, PhD
Assistant Professor, University of Alberta, Faculty of Medicine & Dentistry, Department of Medicine, Division of Nephrology
BIOGRAPHY: Dr. David Collister (he/him/his) completed his MD at the University of
Manitoba, Internal Medicine Residency at the University of Alberta, Nephrology
fellowship at the University of Manitoba and PhD in Health Research Methodology at
McMaster University. He is a clinician-scientist and Assistant Professor in the Division
of Nephrology, Department of Medicine, Faculty of Medicine & Dentistry at the
University of Alberta. His research focuses on symptom management in patients with
kidney disease and specifically in randomized controlled trials of treatments to
alleviate uremic symptoms and prospective cohort studies focused on precision
medicine. He is also interested in the intersection of kidney health with gender
diversity.
What is your interest in clinical trials?
• We need better evidence to inform the care of patients with kidney disease.
Why do you think clinical trials are important?
• They provide the highest level of evidence to inform clinical care.
What is your personal philosophy about clinical trial training specifically or mentorship in general?
• Designing and conducting your own clinical trial and facing its challenges and experiencing its successes is the best way to grow as an investigator.
FUN FACT: I am a patient partner
What is your interest in clinical trials?
• We need better evidence to inform the care of patients with kidney disease.
Why do you think clinical trials are important?
• They provide the highest level of evidence to inform clinical care.
What is your personal philosophy about clinical trial training specifically or mentorship in general?
• Designing and conducting your own clinical trial and facing its challenges and experiencing its successes is the best way to grow as an investigator.
FUN FACT: I am a patient partner
Industry

eNewsletter
SUBSCRIBE NOW
To find out more about Clinical Trials Training Programs in Canada, follow our monthly development and progress
By subscribing, I have read and agree to the Terms of Use and the Privacy Policy.